![]() |
FDA-Approved Afrezza: An Inhaled Alternative to Injecta...
October 1, 2014 - Featured , In the News / Politics By: Elissa Tam, PharmD Candidate c/o 2015 – Patients with Type 1 or Type 2 diabetes who cannot control their glucose levels simply by taking oral medications have to inject insulin daily. They also have to measure their glucose levels by using strips and lancets on a regular basis. For patients, especially elderly ones, the… |
![]() |
Combating Counterfeit Drugs...
October 1, 2014 - Featured , In the News / Politics By: Azia Tariq, Staff Editor – With the sale of counterfeit drugs reaching an alarmingly higher rate than ever, The U.S Food and Drug Administration (FDA) in collaboration with the Skoll Global Threats Fund, the U.S. Pharmacopeia (USP), the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the multi-agency… |
![]() |
Migraine Relief at the Push of a Button...
August 1, 2014 - Featured , In the News / Politics By: Davidta Brown, Senior Staff Editor – A new therapeutic device has seemingly leapt from the pages of a science fiction novel and into the hands of migraine sufferers around the world. Worn over the forehead and sending electromagnetic stimulation directly into the supraorbital trigeminal nerves, the cranial nerve stimulator offered by Belgian biotechnology company… |
![]() |
Grastek®: FDA Approves New Sublingual Immunotherapy fo...
July 1, 2014 - Featured , In the News / Politics By: Kevin Lin, PharmD Candidate c/o 2015 – This April, the FDA approved three sublingual immunotherapies for pollen induced allergic rhinitis: Grastek® (Timothy Grass Pollen Allergen Extract), Oralair® (Grass Pollen Allergen Extract), and Ragwitek® (Short Ragweed Pollen Allergen Extract). Formulated by Merck, Grastek® is Timothy grass pollen allergen extract. It is approved for patients ages… |
![]() |
Evzio™ – New Naloxone Auto-Injector For Opioid Over...
June 1, 2014 - Featured , In the News / Politics By: Diana Gritsenko, PharmD Candidate c/o 2015 – Drug overdose is a serious problem in the United States. In 2010, drug overdose caused more deaths among adults within the ages of 25 and 64 years than motor vehicle accidents. The Center for Disease Control (CDC), ran an analysis that showed drug overdose death rates have… |
![]() |
Tasimelteon (Hetlioz®): First FDA Approved Pharmacolo...
April 1, 2014 - Featured , In the News / Politics By: Beatrisa Popovitz, Senior Staff Editor – On January 31st 2014, the FDA announced the release of a revolutionary new drug, tasimelteon (Hetlioz®). Tasimeleton is the first developed treatment of non-24-hour sleep-wake cycle syndrome in blind individuals.1 Formulated by Vanda Pharmaceuticals Inc., this melatonin receptor agonist works by binding to and activating the MT1 and… |
![]() |
The Importance of Organ Donation: Perspectives and the ...
March 1, 2014 - Featured , Professional Advice / Opinions By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica Melore and Jennifer McDermott, PharmD, BCPS of NewYork-Presbyterian Hospital – Jessica Melore was 16 years old, a senior in high school, and co-captain of the tennis team when her life took a drastic turn. While… |
![]() |
Surviving APPE Rotations...
January 1, 2014 - Professional Advice / Opinions By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 – Starting your rotations in 5th year usually brings mixed emotions. On one hand, it’s a relief to finally be finished with labs and D&Ds…imagine, a whole year without any exams! But on the other hand, now you have to test how… |
![]() |
The Blunt Truth...
January 1, 2014 - Featured , In the News / Politics By: Katharine Cimmino, Editor-in-Chief – Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a very popular illicit drug.1 According to the National Survey on Drug Use and Health, “In 2012, 5.4 million persons aged 12 or older used marijuana on a daily or almost daily basis in the past 12… |
![]() |
Newly Approved: Macitentan (Opsumit®)...
December 1, 2013 - Clinical , Featured By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy – The FDA approved macitentan (Opsumit®) on October 18, 2013 for the treatment of pulmonary arterial hypertension.1 Pulmonary arterial hypertension, often referred to as PAH, is a disease characterized by high blood pressure in the arteries between the heart and lungs. An increase… |
![]() |
Possible Inhaled Option for Diabetics...
December 1, 2013 - In the News / Politics By: Sang Hyo Kim, Staff Editor – Near the end of December, the pharmaceutical company, MannKind Corp, will submit their clinical data to the U.S Food and Drug Administration for the approval of an inhaled dosage form of insulin, Afrezza®.1 Administered with the Dreamboat inhaler, this inhaled dosage form delivers insulin packaged into single dose… |
![]() |
Zecuity(TM): Novel Treatment Option for Migraines...
November 1, 2013 - Clinical By: Arya Mathew, PharmD Candidate c/o 2014 – About twelve percent of the U.S. population suffers from migraines, affecting adult women three times more than adult men. Migraines are returning attacks of moderate to severe, throbbing or pulsing pain, usually on one side of the head. Along with the severe pain, migraine sufferers also experience… |
![]() |
An Interview with Dr. Barile: Professor, Reseacher, and...
September 1, 2013 - Professional Advice / Opinions By: Katharine Cimmino, Editor-in-Chief & Bharat Kirthivasan, Co-Copy Editor – Frank A. Barile Ph.D. is a Professor of Clinical and Applied Toxicology at St. John’s University. He is also a St. John’s University alumnus, having received a B.S. in Pharmaceutical Science, an M.S. in Toxicology, and a Ph.D. in Pharmacology. At St. John’s University, Dr.… |
![]() |
HIV Test: Making a Difference...
September 1, 2013 - In the News / Politics By: Sang Hyo Kim, Staff Editor – On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov, and other national and local entities organized the 19th annual National HIV Testing Day. On this day, the theme of “Take the Test, Take Control” was employed to spread awareness of testing and prevention methods… |
![]() |
Two New Agents for the Treatment of Obesity...
August 1, 2013 - Clinical , Featured By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU – Obesity is defined as having a body mass index (BMI) of 30 kg/m2 or greater. It is thought to be the result of an imbalance between energy intake and energy expenditure, possibly due to a number of genetic and environmental factors.1 It is estimated… |
![]() |
Understanding Opioid Overdose...
July 1, 2013 - Clinical , Featured By: Aleena Cherian, PharmD Candidate c/o 2014 – Although opioid analgesics are among the most effective drugs to treat pain, they are associated with a growing number of public health issues including addiction and severe, often fatal, overdoses. The recent increase in incidences of opioid overdose is directly correlated to rapidly increasing and widespread use… |
![]() |
New P2Y12 Antagonist on the Rise...
April 1, 2013 - Clinical By Nancy Rizkalla, PharmD candidate c/o 2015 – Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly effective approach in reducing the risk of death or ischemic complications following a myocardial infarction as well as improving the quality of life in patients with stable angina. PCI is ultimately performed in 60 –… |
![]() |
Happy Holidays and Best Wishes for 2012!...
December 1, 2012 - Professional Advice / Opinions Dear Readers, Christmas is just a few days away, and an amazing year of great challenges, pleasant surprises, and endeavors is coming to a close. From working on your Drugs & Diseases courses to simply having the privilege of being part of the profession at the White Coat Ceremony, the students have endured much and… |
![]() |
Giving a Second Chance: The Prescription Drug Abuse Epi...
December 1, 2012 - Featured , In the News / Politics , Professional Advice / Opinions By: Maria Sorbera, PharmD Candidate c/o 2013 at AMSCOP (LIU) – Author William S. Burroughs states in his novel, “The question is frequently asked: Why does a man become a drug addict? The answer is that he usually does not intend to become an addict. You don’t wake up one morning and decide to be… |
![]() |
Safety and Efficacy of Atropine for Salivary Hypersecre...
November 1, 2012 - Clinical By: Elsa Thomas, PharmD Candidate c/o 2013 – Atropine is an anticholinergic used to treat various conditions, such as bradycardia, neuromuscular blockade, mydriasis, nerve agent poisoning, and salivary hypersecretion.1,2 Pharmacologically, it inhibits smooth muscle and glands innervated by postganglionic cholinergic nerves.1,2 It also has functions in the central nervous system (CNS); it could stimulate or… |
![]() |
Influenza Vaccines: Projected Strains for the 2012—20...
September 1, 2012 - Clinical , Featured By: Joo Hee Kwon, Pharm.D. Candidate c/o 2013 – There are 3 antigenic types of influenza: A, B, and C. Influenza C causes mild illness and therefore does not cause epidemics. In contrast, influenza A and B are capable of causing mild to severe flu and in some cases death. An epidemic can occur depending… |
![]() |
Student Spotlight: Felipe Camacho...
September 1, 2012 - Professional Advice / Opinions By Nandini Puranprashad, Pharm D. Candidate c/o 2013 – Felipe Camacho is a 6th year student at the University of Florida College of Pharmacy. He received his Bachelors of Arts in Music Composition from Rollins College, Winter Park, FL. After graduation, Mr. Camacho plans to pursue a residency at the Veterans Affairs (V.A.), Lee Memorial… |
![]() |
Matching Challenge: Over-the-Counter Products...
August 1, 2012 - Puzzles By: Mohamed Dungersi, Associate Student Editor – Match the following herbal products with their correct description: A. This product has been used to treat liver disease, including hepatitis and cirrhosis. It has also been used as a protective agent after the liver was exposed to alcohol, acetaminophen, and carbon tetrachloride.B. This product is extracted from… |
![]() |
Effect of Intravenous Ondansetron on QT Interval Prolon...
June 1, 2012 - Clinical By: Raymond Wu, Pharm.D. Candidate c/o 2013 The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used in the prevention and treatment of nausea and vomiting in the inpatient setting.1 Overall, ondansetron is a well-tolerated medication with few side effects.1 Constipation, dizziness, and headache are the most commonly reported side effects associated… |
![]() |
My Experience within the American College of Clinical P...
May 1, 2012 - Professional Advice / Opinions By: Alissa Karr, Purdue University College of Pharmacy Pharm.D. Candidate c/o 2012 – Alissa Karr is a PharmD Graduate from Purdue University College of Pharmacy, Class of 2012. She is the current secretary of the American College of Clinical Pharmacy (ACCP) StuNet Advisory Committee. Her post-graduation plans are to obtain a pharmacy practice… |
![]() |
Eight Ways to Kick the Habit...
April 1, 2012 - Clinical , Professional Advice / Opinions By: Nagma Gargi, Pharm.D. Candidate c/o 2013 – Smoking cessation programs are extremely important in our society as increasing evidence emerges showing the correlation between smoking and the risk factors for various disease states. Thus as professionals it is our duty to educate ourselves first, then our patients. In this article, I want to discuss… |
![]() |
The 2011 ASHP Midyear Clinical Meeting – New Orleans,...
January 1, 2012 - Events , Professional Advice / Opinions By: Anon, Pharm.D. Candidate c/o 2012 – This year’s ASHP Midyear Clinical Meeting took place in New Orleans, Louisiana from December 4 – 8, 2011. It was a keystone moment for many pharmacy students, and especially for those in their final year and in pursuit of a residency, fellowship, or hospital staffing position around the… |
![]() |
Clevidipine in the Management of Hypertensive Emergency...
January 1, 2012 - Clinical , Featured By: Neal Shah – Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than or equal to 140 mmHg and a diastolic blood pressure (DBP) greater than or equal to 90 mmHg. Patients with Stage 1 HTN have a SBP between 140 and 159 mmHg and DBP between 90… |
![]() |
Alumni Spotlight: Reducing Medication Dispensing Errors...
December 1, 2011 - Featured , Professional Advice / Opinions By: Joseph Saffi, RPh – Joseph Saffi is a St. John’s University College of Pharmacy graduate, class of 1985. He is currently the supervising pharmacist at Pathmark Pharmacy of Franklin Square in Long Island, New York, and has been working for Pathmark pharmacies since 1988. Mr. Saffi is also a community pharmacy preceptor with St.… |
![]() |
Happy Holidays and Best Wishes for 2012!...
December 1, 2011 - Professional Advice / Opinions By: Ebey P. Soman – Dear Sir or Madam, Christmas is just a few days away, and an amazing year of great challenges, pleasant surprises, and endeavors is coming to a close. From working on Drugs & Diseases courses to simply having the privilege of being part of the profession at the White Coat Ceremony,… |
![]() |
SpongeBob SquarePants… Harmful?...
November 1, 2011 - Clinical , Featured By: Ebey P. Soman – Current research demonstrates a strong correlation between the length of time a child watches television and decreased long-term attention deficiency disorders. A new study by Lillard and Peterson at the Department of Psychology at the University of Virginia suggests that the popular children‘s television show, SpongeBob SquarePants, might be harmful.… |
![]() |
Event Spotlight: Mock Residency Interviews...
November 1, 2011 - Events By: Neal Shah – As the year comes to a close, many pharmacy students are turning their sights onto the process of residency interviews. Residencies provide a competitive edge and an educational fulfillment to future pharmacists who wish to engage in clinical practice. On October 26th, Rho Chi held its first Mock Residency Interviews, open… |
![]() |
Event Spotlight: Rho Chi General Body Meeting...
October 1, 2011 - Events By Marie Huang – On September 22nd, members of Rho Chi gathered in Sullivan Hall Room 306 for the first General Body Meeting of the semester. As President Mohamed Dungersi stepped to the front of the room and reintroduced the executive board, students quietly helped themselves to scrumptious, hot slices of Domino‟s Pizza, and retreated… |